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Background: Solid tumours can undergo cycles of hypoxia, followed by reoxygenation, which can have significant implications for
the success of anticancer therapies. A need therefore exists to develop methods to aid its detection and to further characterise its
biological basis. We present here a novel method for decomposing systemic and tumour-specific contributions to fluctuations in
tumour deoxyhaemoglobin concentration, based on magnetic resonance imaging measurements.
Methods: Fluctuations in deoxyhaemoglobin concentration in two tumour xenograft models of colorectal carcinoma were
decomposed into distinct contributions using independent component analysis. These components were then correlated with
systemic pulse oximetry measurements to assess the influence of systemic variations in blood oxygenation in tumours, compared
with those that arise within the tumour itself (tumour-specific). Immunohistochemical staining was used to assess the physiological
basis of each source of fluctuation.
Results: Systemic fluctuations in blood oxygenation were found to contribute to cycling hypoxia in tumours, but tumour-specific
fluctuations were also evident. Moreover, the size of the tumours was found to influence the degree of systemic, but not tumour-specific,
oscillations. The degree of vessel maturation was related to the amplitude of tumour-specific, but not systemic, oscillations.
Conclusions: Our results provide further insights into the complexity of spontaneous fluctuations in tumour oxygenation
and its relationship with tumour pathophysiology. These observations could be used to develop improved drug delivery
strategies.
The structure of tumour vasculature is typically disorganised, with
blood vessels that are tortuous, dilated, elongated and leaky, with
saccular and dead-end formations (Carmeliet and Jain, 2000;
Heldin et al, 2004). This vascular architecture, combined with long
intervascular distances relative to the oxygen diffusion distance
(Thomlinson and Gray, 1955), intravascular gradients of oxygen
tension (Dewhirst et al, 1999) and increased blood viscosity
(Kavanagh et al, 1993), contributes to the presence of regions of
persistent low oxygen tension, or chronic hypoxia (Dewhirst,
1998).
Tumours can also exhibit regions with temporally variable
oxygenation. This can be caused by phenomena such as arteriolar
vasoconstrictive motion (vasomotion; Dewhirst et al, 1996), rapid
vascular remodelling (Patan et al, 1996) and raised interstitial fluid
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pressure (Mollica et al, 2003), each of which can contribute to the
observed spontaneous fluctuations in tumour blood flow and red
blood cell flow (Kimura et al, 1996; Mollica et al, 2003). These are
thought to be the cause of cycles of low oxygen tension with
subsequent reoxygenation, a phenomenon known as cycling
(or fluctuating) hypoxia (Chaplin et al, 1987; Kimura et al, 1996;
Matsumoto et al, 2010).
Cycling levels of oxygenation have several significant implications
for therapy. For example, they are a major cause of resistance to
radiation therapy, owing to decreased number of reactive oxygen
species (Martinive et al, 2006b) and reduced oxygen-induced
stabilisation effect of DNA damage (Harrison and Blackwell,
2004). It also impacts negatively on the delivery of systematically
administered chemotherapeutic agents, due to impairment of
regional blood flow (which has further implications as the activity
of some chemotherapeutic drugs is altered at low oxygen
concentration; Durand, 2001; Chou et al, 2012). In addition, there
is evidence that oxygen fluctuations can cause an increase in
metastatic potential (Cairns et al, 2001). A deeper understanding of
the tumour microenvironment and the influences behind these
transient changes in oxygenation is therefore warranted.
Gradient-echo magnetic resonance imaging (GRE-MRI)
sequences can be used to estimate blood oxygen variations non-
invasively by mapping the blood oxygen level-dependent (BOLD)
effect (Baudelet and Gallez, 2005). BOLD imaging uses the
endogenous magnetic properties of deoxyhaemoglobin as a source
of image contrast (Ogawa et al, 1990). Deoxyhaemoglobin is
paramagnetic, and so an increase in deoxyhaemoglobin concentra-
tion can be detected in the decay of the GRE-MRI signal. This is
quantified via the transverse relaxation rate (R2*¼ 1/T2*).
Consequently, blood oxygen fluctuations that are characteristic of
cycling hypoxia can be estimated with measurements of temporal
changes in R2* (Prasad et al, 1996). Gradient-echo imaging has
been used in a number of studies to assess spontaneous cycling
hypoxia events, which have aimed to identify the frequencies of
such oscillations (Baudelet et al, 2004, 2006).
These fluctuations are complex and heterogeneously distributed
throughout each tumour, and techniques to further evaluate and
characterise them would allow the fluctuations to be better
understood. To this end, we have adopted a technique that is
now widely used in BOLD studies of the brain, named independent
component analysis (ICA), which allows a signal to be decomposed
into its constituent components. In the brain, ICA has been used to
identify spatially coherent fluctuations in blood oxygenation that
are associated with regions that are functionally connected (van de
Ven et al, 2004; Beckmann et al, 2005; Kundu et al, 2013). By
analogy, we propose that ICA could be used to identify regional
connectivity within tumours, albeit reflecting different biological
mechanisms to those in the brain, alongside the ability to study
such signals in isolation, provide information on the sources of
such fluctuations and investigate their relationship with variations
in the tumour microenvironment. In this study, we provide an
initial evaluation of the BOLD–ICA technique in two mouse
xenograft models of colorectal carcinoma. We then use it in
combination with pulse oximetry to identify contributions to
tumour BOLD signal variations caused by changes in systemic
blood oxygenation, thereby enabling fluctuations caused specifi-
cally by tumour pathophysiology to be isolated.
MATERIALS AND METHODS
Animal models. All experiments were performed in accordance
with the local ethical review panel, the UK Home Office Animals
Scientific Procedures Act 1986, and United Kingdom Co-ordinating
Committee on Cancer Research guidelines (Workman et al, 2010).
To propagate tumours, 5 106 human colorectal adenocarcinoma
cells (LS174T or SW1222) were injected subcutaneously into the
flank of immunocompromised CD1 female nude mice (8 weeks of
age, 20–25 g). These two cell lines develop into xenografts with
markedly different phenotypes: SW1222 tumours are well-
differentiated with clearly defined glandular structures and an
extensive and well-perfused vascular network, whereas LS174T
tumours show moderate-to-poor differentiation and are compara-
tively less-well vascularised and perfused, with larger hypoxic and
necrotic regions (Pedley et al, 2002; El-Emir et al, 2005; Folarin
et al, 2010). Mice were scanned at 2 weeks following inoculation,
and tumour volumes ranged from 135 to 670mm3. A summary of
the data acquisition and post-processing is shown in Figure 1A.
In vivo MRI. Mice bearing LS174T (n¼ 5) or SW1222 (n¼ 5)
xenografts were anaesthetised using isoflurane in air and secured in
a cradle using dental paste to minimise motion (Landuyt et al,
2002; Burrell et al, 2011). Warm air and water were used to
maintain normothermia. Core temperature and respiratory rate
were monitored using a rectal thermometer and a pressure pad,
respectively (SA Instruments, Stony Brook, NY, USA). All MRI
data were acquired using a horizontal bore 9.4 T scanner (Agilent
Technologies, Santa Clara, CA, USA). Fast spin-echo (FSE) images
were initially acquired for anatomical reference, from which we
measured the tumour volume. We then acquired dynamic
gradient-echo multi slice (GEMS) images, in order to map
the temporal variation of the tumour relaxation rate, R2*.
Imaging parameters for the FSE acquisition were: in-plane
field of view 35 35mm2, matrix size 128 128, slice thickness
1mm, 20 slices. For the GEMS sequence we used: in-plane field of
view 20 20mm2, matrix size 64 64, slice thickness 1.5mm,
5 slices, 3.8 s per image, total acquisition time for one animal
was 60min.
In vivo pulse oximetry. During the acquisition of GEMS data,
pulse oximetry recordings were obtained with a sensor clamped to
the thigh of the animal (MouseOx, Starr Life Sciences, Oakmont,
PA, USA), which allowed the direct measurement of systemic
arterial oxyhaemoglobin saturation (O2sat).
Model for MRI data decomposition. Tumour R2* time-courses
(see Figure 1B, inset graphs) were first processed using principal
component analysis (PCA), a computational technique that allows
the extraction of the highest variance components in the data, and
which is usually applied to highly dimensional data sets. In PCA, the
variance in the data is associated to eigenvectors in a decreasing
rank-order fashion, so that the first eigenvector has the largest
variance, the second eigenvector has the second largest variance and
so on (Shlens, 2014). This ordered process results in the last
eigenvectors having very little variance, being thus ascribed to
background noise (Shlens, 2014). Dimensionality reduction of the
R2* data was then performed. This was achieved by selecting all the
eigenvectors up to the ‘shoulder’ of the PCA decomposition curve
(see Figure 1C), as well as the eigenvectors after that point
which were associated with a time-course exhibiting a dominant
frequency peak. On average, 89 out of 944 eigenvectors per data
set were chosen (n¼ 10). This pre-processing procedure was
performed for two reasons: (i) it allowed the subsequent ICA
decomposition of the data to be simplified, because the great
majority of the variance is concentrated on a reduced number of
eigenvectors, meaning all the data can be explained in fewer
components, and (ii) by doing so, we expect to filter out some
of the background noise, which also facilitates the ICA
decomposition (Shlens, 2014).
Spatial ICA was then applied to this dimensionally reduced data
(FastICA v2.5, Espoo, Finland; Hyvarinen, 1999), allowing the
linear superposition of signals that compose the R2* estimates to be
separated into independent processes (or components). Each
independent component has a (previously unknown) unique
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time-course and an associated spatial map, and can be studied
individually. The decomposition process was modelled as:
X ¼ MS ð1Þ
where X is the voxel-wise matrix of R2* time-courses, M is the
‘mixing’ matrix, whose columns are filled with the component
time-courses derived from the decomposition, and the rows of S
contain the generated spatial maps. Separation between systemic
and tumour-specific influences on tumour R2* fluctuations
was undertaken by correlating each independent component
time-course with the systemic O2sat time-course (Pearson’s linear
correlation). A significant correlation (Po0.01) suggested that the
current independent component represented systemic blood
oxygen dynamics. Conversely, if the correlation was less significant
(P40.01), the time-course of the independent component, its
frequency spectrum and its spatial map were studied in order to
assess if it was a component modelling tumour-specific dynamics.
Two selection criteria were adopted: (i) if the frequency spectrum
presented a peak at a defined frequency, this was enough evidence
of cycling behaviour, or (ii) if the independent component spatial
maps, which were normalised and thresholded by z-value
(|z-score|X2.2; van de Ven et al, 2004), presented clustering
regions (minimum of 5 voxels), this meant that those regions
shared a degree of similarity in their R2* dynamics. To improve the
robustness of the second selection criteria, we only selected the
components that exhibited spatial clustering regions associated
with non noisy-like (distinctive) temporal features, in order to
prevent noisy independent components from being considered
(see Figure 1D). Any remaining components (i.e., ones with poor
correlation and that did not exhibit a frequency peak or spatial
clustering effects), were considered to be modelling any back-
ground noise not previously filtered by PCA and were not
considered for further analysis.
Thus, this framework provides a method to potentially separate
systemic from tumour-specific cycling hypoxia events in tumours.
Because each component time-course has an associated component
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Figure 1. Data acquisition and post-processing. (A) Timeline of data acquisition and post-processing methods. (B) Voxel-wise standard deviation
(s.d.) maps of the R2* fluctuations in example, representative, LS174T and SW1222 tumours, before any processing. s.d. maps are shown overlaid
on T2-weighted images. High amplitude fluctuations, which are shown in the inset graphs, have larger s.d. values. (C) PCA decomposition curve
showing the relative variance associated with each eigenvector. Eigenvectors to the left of the ‘shoulder’ of the curve have high variance. (D) Time-
course and 3D spatial map of one independent component in an example SW1222 tumour.
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spatial map, we combined these two pieces of information to
recover the R2* data, although now separated into systemic and
tumour-specific influences, in a process which is the reverse of the
ICA decomposition:
R2 ICA sys ¼ MsysSsys
R2 ICA ts ¼ MtsSts ð2Þ
where R2 ICA sys and R

2 ICA ts are the voxel-wise matrices of systemic
and tumour-specific R2* time-courses, respectively. Lastly, to
threshold R2 ICA sys, a final correlation between the systemic O2sat
and the time-courses of individual voxels of R2 ICA sys was
computed (Pearson’s linear correlation). Only the most significant
correlations (Po0.01) were selected to represent systemically
oscillating tumour regions. A similar procedure was employed to
detect the most tumour-specific fluctuating areas, where only
non-significant correlations (P40.05) between the systemic O2sat
and the dynamics of R2 ICA ts were considered.
Frequency analysis. Time-courses of thresholded R2 ICA sys and
R2 ICA ts were analysed in the frequency domain, for both tumour
lines. For each tumour, individual voxel time-courses were Fourier
transformed and subsequently combined into a single average-
frequency spectrum. The spectral mean and standard deviation
(s.d.) of the cohort of tumours was then computed. Dominant
frequencies of oscillation were assessed based on spectral power
(peak height).
Histology and immunostaining. To investigate the pathophysiol-
ogy underpinning fluctuations in BOLD-ICA measurements, we
performed multifluorescence labelling of 10mm-thick frozen sections
of tumour tissue. Following MRI, care was taken to preserve the
orientation of the tumour upon excision and during histological
preparation, so that tumour sections were cut in the same plane as
the MRI acquisition. Histology could not be performed on one
LS174T tumour due to sample degradation following excision. We
obtained distributions of vascular perfusion, vascular endothelial
cells, pericytes and hypoxic regions in all tumours. Perfusion staining
was achieved via intravenous injection (12.5mgkg 1) of the
blue fluorescent marker Hoechst 33342 (Cambridge Bioscience,
Cambridge, UK) 1min before killing the animal. Endothelial cells
were stained with a rat monoclonal antibody against CD31 (Abcam,
Cambridge, UK), revealed with Alexa Fluor-488 (Life Technologies,
Paisley, UK). Pericytes were detected by a-smooth muscle actin
(a-SMA) staining with a mouse monoclonal anti-a-SMA (Sigma-
Aldrich, Gillingham, UK), revealed with Alexa Fluor-546 (Life
Technologies). Hypoxic regions were detected via intraperitoneal
injection (60mgkg 1) of the hypoxia marker pimonidazole
(Hypoxyprobe, Burlington, MA, USA) 30min before killing the
animal, followed by ex vivo staining using a rabbit polyclonal anti-
pimonidazole (Hypoxyprobe), revealed with Alexa Fluor-488 (Life
Technologies). In addition, haematoxylin and eosin (H&E) staining
was performed in immediately adjacent frozen sections to assess
tumour morphology.
Fluorescence images were taken on an Axio Imager microscope
(Carl Zeiss, Cambridge, UK), using an AxioCam digital colour
camera. Images of H&E were collected on a bright-field Zeiss
Axioskop2 microscope (Carl Zeiss). Both microscopes were fitted
with a motorised stage and used AxioVision software (Carl Zeiss).
Quantification of immunofluorescence was performed in
Matlab software (The MathWorks, Natick, MA, USA). Regions
of interest (ROIs) were drawn around the total area of the tumour
and images were thresholded to exclude background fluorescence
signal. Tumour coverage of each of the four fluorescent markers
was calculated as the ratio between fluorescent pixels and the total
number of pixels within the ROI. In addition, the percentage of
capillaries (CD31) covered with pericytes (a-SMA) was calculated
to assess vascular maturation.
Statistical analysis. Matlab software was used to perform
statistical analysis. Assessment of linear correlation between
O2sat and ICA time-courses was achieved by the Pearson’s
correlation coefficient and further transformed into a t-statistic
to obtain P-values. For statistical comparisons between tumour size
and other whole-tumour measurements, smaller sample numbers
required the use of non-parametric statistics. Wilcoxon matched-
pairs tests were used to compare between systemic and tumour-
specific distributions. Mann-Whitney U-tests were used to assess
differences between tumour types. Spearman’s rho was used for
correlation assessments. Po0.05 was considered to be significant,
unless otherwise stated.
RESULTS
Assessment of temporal and spatial variations in tumour
R2*. Temporal fluctuations in R2* time-courses (derived from
BOLD MRI measurements), which are thought to be caused by
changes in deoxyhaemoglobin concentration, were observed in
both LS174T and SW1222 tumour types. Example time-courses are
shown in Figure 1B, alongside a map of the temporal s.d., which
showed a heterogeneous distribution across the tumour. According
to spectral analysis, the mean peak frequency in R2* time-courses
was in the range inferior to 0.001Hz (i.e.,o3.6 cycles h 1) for both
tumour types. R2* values between SW1222 and LS174T tumours
were 0.12±0.02ms 1 and 0.08±0.02ms 1 (mean±s.d.),
respectively, which were not significantly different (P40.05,
Mann-Whitney U-test). However, as we are interested in temporal
fluctuations, the relative variations in R2* assume greater
importance than the actual R2* values. Moreover, it was shown
that the absolute value of R2* (or T2*) does not reliably predict pO2
in vivo, although a good temporal correlation between these two
quantities was observed (Baudelet and Gallez, 2002).
Decomposition of R2* time-courses using ICA produced, on
average, 89 separate components; one component is shown
in Figure 1D. Regional clustering was observed in the ICA
spatial maps, which were thresholded by z-score (z-scoreo 2.2
or z-score42.2), suggestive of spatial coherence in R2* fluctuation
patterns (Figure 1D). This effect is often observed across several
imaging slices, as demonstrated by the 3D representation, which
suggests temporally coherent patterns over a tumour volume. The
pathophysiological basis for such regions is discussed below.
Relationship between systemic and tumour-specific influences
on tumour R2* fluctuations. Alongside BOLD MRI data, pulse
oximetry measurements were also acquired. An important aim of this
study was to investigate, using ICA and pulse oximetry (ICA-O2sat),
whether such tumour spontaneous fluctuations included contribu-
tions from systemic variations in blood oxygenation.
Figure 2 shows an example SW1222 tumour, in which the
ICA-O2sat model enabled the identification of R2* time-courses
that were significantly correlated with systemic blood oxygen
variations (Po0.01, Pearson’s correlation; R2 ICA sys). In addition,
we observed R2* temporal patterns that were not correlated with
systemic blood oxygen variations (P40.05, Pearson’s correlation),
which we considered to be specific to the tumour microenvironment
(R2 ICA ts). These two types of oscillation could, however, be found in
the same voxel and were not necessarily from discrete regions in the
tumour. Both systemic and tumour-specific contributions were
observed in all SW1222 (n¼ 5) and LS174T (n¼ 5) tumours.
Figure 3A shows the percentage of voxels exhibiting systemic
or tumour-specific R2* fluctuations in each tumour line. The
majority of SW1222 and LS174T tumours (4 out of 5 in each
group) showed a greater occurrence of tumour-specific fluctua-
tions than systemic fluctuations, although the difference was not
statistically significant (both tumour lines: P¼ 0.125, Wilcoxon
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matched-pairs test). A similar result was observed in the s.d. of
R2* fluctuations (Figure 3B), in which tumour-specific fluctua-
tions were of higher magnitude in all but one SW1222 or LS174T
tumours (SW1222: P¼ 0.125, LS174T: P¼ 0.3125, Wilcoxon
matched-pairs test).
All LS174T tumours exhibited large systemic fluctuations in the
tumour periphery (Figure 3C), whereas tumour-specific fluctua-
tions were observed in both the centre and the periphery.
Conversely, systemic and tumour-specific fluctuations were
distributed throughout SW1222 tumours.
Dominant frequencies for each type of fluctuation, assessed
from the peak height of frequency spectra, were not significantly
different in either tumour type, being both in a low-frequency
range, inferior to 3.6 cycles h 1 (Figure 4). This result further
demonstrates the discriminatory ability of the ICA-O2sat model, as
similar frequencies were not a limiting factor in separating
systemic and tumour-specific sources.
Physiological basis of tumour fluctuations. Fluorescently
labelled tumour sections revealed significant differences between
tumour types, with SW1222 showing a more extensive vascular
network (CD31), which was better perfused (Hoechst 33342) and
less hypoxic (pimonidazole) than in LS174T tumours (Figure 5A
and B). These observations are in accordance with previous
studies (Pedley et al, 2002; El-Emir et al, 2005). Furthermore,
visual inspection of H&E sections confirmed the different
morphology of each tumour line, with SW1222 tumours showing
better differentiation into glandular structures, which is in
agreement with previous literature (Figure 5A; Folarin et al, 2010).
The percentage of each tumour that exhibited R2* fluctuations due
to systemic influences was significantly correlated with tumour volume
(Figure 6A). There was no correlation between tumour volume and the
percentage of each tumour exhibiting tumour-specific fluctuations
(Figure 6B). However, comparison of histological measures with MRI
data revealed a significant inverse correlation between the magnitude of
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tumour-specific fluctuations and the percentage of mature vessels
(assessed by co-localisation of a-SMA and CD31 immunostaining,
Figure 6C). No correlation was found between the percentage of mature
vessels in each tumour and the size of the tumour, nor with the
prevalence or magnitude of systemic fluctuations.
The percentage of pericytes, alongside the degree of attachment
to tumour blood vessels, was not significantly different between
the tumour types (Figure 5B). However, we observed that, in
tumour sub-regions with high systemic or tumour-specific
R2* variation, tissues were well perfused and viable (non-necrotic)
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in 4 SW1222 (n¼ 5) and 3 LS174T (n¼ 4) tumours (see Figure 5A
and C for LS174T; see Figures 2A and 5A for SW1222).
DISCUSSION
In this study we have presented a novel technique, based on ICA,
for characterising individual contributions to cycling hypoxia in
tumours. Specifically, our approach was designed to separate
systemic from tumour-specific sources of R2* variation (an MRI
estimate of blood oxygenation) in individual tumours, whilst
attempting to remove the influence of background noise inherent
in the MRI acquisition process. This allowed the identification of
the areas mostly affected by either mechanism in individual
tumours. Low-frequency fluctuations in oxygen tension and blood
flow were previously observed in both tumour and muscle by
Braun et al (1999), using recessed-tip oxygen microelectrodes and
laser-Doppler flow probes. Despite having observed greater low-
frequency activity and greater magnitude changes in tumours, this
provided an early suggestion for systemic influences. Baudelet et al
(2004) also reported a similar observation when comparing
T2*-weighted gradient-echo fluctuations between tumour and
contralateral muscle. They additionally looked at whether muscle
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and tumour time series were correlated, and concluded systemic
changes did not affect the tumour microenvironment because
no significant results were obtained. The technique presented
here is, however, more refined, as it isolates high-variance data
and separates the multitude of processes contributing to R2*
fluctuations before any time series correlation. Moreover, the
ICA-O2sat model provides the unique advantage of being able to
identify tumour regions that are simultaneously suffering from
systemic and tumour-specific effects, which would be otherwise
impossible, that is, if direct correlations were used without prior
ICA decomposition.
We observed that systemically driven, high-amplitude fluctua-
tions were preferentially located in the tumour periphery in LS174T
tumours, whereas in SW1222 tumours there was no preferential
location. This observation is potentially due to the less extensive
vascular network evident in LS174T tumours, compared with
SW1222 tumours. Fewer blood vessels can lead to impaired
perfusion which, in combination with the higher microvascular
density in the LS174T tumour periphery, potentially reduces the
influence of systemic variations in the central area of the tumour. A
similar observation was reported in an MRI study of A-07
melanoma xenografts, where blood flow fluctuations occurred
preferentially in the tumour periphery, in which case the authors
considered vasomotor activity in the supplying vasculature as a
probable cause of fluctuations (Brurberg et al, 2007). Conversely,
SW1222 tumours have a vascular tree closer to that of normal
tissues, leading to greater perfusion throughout the tumour (and less
hypoxia), and potentially allowing the transmission of systemic
variations from the tumour edge towards its core more effectively.
An important point to note in this regard is that, given the small
percentage of hypoxic areas in SW1222 tumours, the observed R2*
fluctuations in these tumours might not correspond to cycling
hypoxia, but rather to oscillations in the blood oxygenation that
remains within normal oxygenation levels. In this case, ‘cycling
oxygenation’ might be a more accurate term than ‘cycling hypoxia’.
Systemic and tumour-specific sources of R2* oscillations were
further assessed by comparing the percentage of oscillating voxels
with the tumour size. The occurrence of systemic, but not tumour-
specific, R2* oscillations was found to be directly related to the size
of tumours in both SW1222 and LS174T xenografts. Related to
this, Chaplin et al (1986) had previously reported a relationship
between the occurrence of cycling hypoxia and the size of SCCVII
tumours. In their study, they injected the fluorescent perfusion
marker Hoechst 33342 20min before applying 10Gy of radiation
to tumours. Subsequently, a large differential survival between
well-perfused cells and poorly perfused cells was observed in small
tumours (r200mg). However, this difference decreased as the
tumour size increased, which they inferred was due to a higher
occurrence of cycling hypoxia in larger tumours, which acted as a
protective mechanism against radiation. They suggested this
relationship could also depend on tumour type and site of
implantation. Given the results of the current study, we
hypothesise that, as tumours develop and acquire an increased
blood supply from the surrounding vasculature, the influence of
systemic blood flow variations in the tumour becomes increasingly
prevalent. Such effects can potentially occur by (i) an increase in
the number of systemic feeding vessels accompanying tumour
growth or (ii) an increase in the diameter of those vessels.
Nonetheless, to the best of our knowledge, the evolution of the
tumour feeding vasculature has not yet been directly investigated
and a study of this nature would provide valuable information
about the systemic influences on tumour cycling hypoxia.
Oscillations in R2* estimates additionally revealed a link to
tumour biology. The amplitude of tumour-specific fluctuations was
found to be inversely correlated to the degree of vessel maturation
in SW1222 and LS174T tumours, but no similar relationship was
found with systemic fluctuations. This illustrates a key benefit of
the method developed in this study, in that isolation of tumour-
specific fluctuations from those occurring owing to systemic
influence allows a clear insight into tumour pathophysiology.
Interpretation of this finding relies on the role of mural cells in the
structural support of blood vessels: mature vessels have increased
integrity and stability (Murakami, 2012), thus being less susceptible
to mechanical stress-related microenvironmental factors respon-
sible for cycling hypoxia, such as raised interstitial fluid pressure
(Mollica et al, 2003). This interpretation is in agreement with a
previous electron paramagnetic resonance imaging study of two
carcinoma models, which suggested an inverse relationship
between the maturity of the tumour microvascular network and
the amplitude of tissue pO2 fluctuations (Yasui et al, 2010).
A similar conclusion was reported in a related study of melanoma
and cervical carcinoma xenografts, where the presence of
connective tissue embedding the tumour microvessels was
associated with stabilisation of blood flow and tissue pO2
fluctuations (Ellingsen et al, 2012). Moreover, T2*-weighted MRI
estimates of pO2 and blood flow in syngeneic fibrosarcoma-II
tumours previously showed that signal fluctuations occur pre-
dominantly in regions of immature vasculature (Baudelet et al, 2006).
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Vasomotion of mature vessels may still be an important fluctuating
source in some tumour types (Martinive et al, 2006a).
The dominant oscillatory frequencies of R2* estimates reported
in this study occurred at or below 1 10 3Hz (o3.6 cycles h 1).
These time scales are in the same range of the cycling hypoxia
periods first reported by Chaplin and colleagues in a number of
different preclinical tumour models (Chaplin et al, 1986;
Minchinton et al, 1990). Using a fluorescence-activated cell sorting
technique combined with radiation, they inferred cycles of hypoxia
with a periodicity of 20–30min. Almost two decades later, Ca´rdenas-
Navia et al (2004) used recessed-tip oxygen microelectrodes to
directly measure tumour pO2 fluctuations, which were observed to
occur between 2 and 5 cycles h 1 in two different preclinical tumour
lines. A number of other studies in different tumour lines reported
fluctuating periods between 20 and 60min (Dewhirst et al, 1996; Hill
et al, 1996; Kimura et al, 1996). Less anticipated was the finding that
systemic and tumour-specific R2* patterns oscillate in a similar
frequency range. One possible issue has to do with the protocol used
in this study. The sampling frequency of acquisition, 3.8 s per image
(B0.13Hz), might not be fast enough to prevent signal interference
from high-frequency oscillations. Indeed, Kalcher et al (2014)
observed, using two different MRI signal acquisition rates, that the
high-frequency proportions of signal fluctuations in the brain were
folded into the low-frequency range when they used the low
acquisition rate (B0.25Hz). This was evident upon comparison with
spectral distributions of data acquired with a high rate (B1.4Hz).
Conversely, scan times longer than those used in this study could
help resolve any differences in the low-frequency range, either
between systemic and tumour-specific sources or between tumour
lines.
Besides the potential issues due to the relatively low-sampling
rate of acquisition, the approach used in this study suffers from
additional limitations. Estimating blood oxygenation variations
with gradient-echo MRI can have confounding effects, as R2*
changes can also reflect changes in blood volume, blood pH,
haematocrit or in the fraction of oxygen extraction by the tissue
(Howe et al, 2001). In addition, the ICA-O2sat model, as
implemented here, did not consider any possible lag between the
O2sat variations and tumour R2* fluctuations. However, the
circulation time in mice is of the order of the temporal resolution
of the GRE acquisition used in this study, so such effects can be
assumed to be negligible. Finally, systemic influences in the tumour
microenvironment can come from different sources, such as
pulsatile flow and blood pressure, in addition to blood oxygena-
tion, which might render the ICA-O2sat model an over-simplistic
approach.
Nevertheless, the ICA-O2sat model is a non-invasive and
novel approach to directly identify systemic influences on tumour
cycling hypoxia patterns. We consider it has the potential to
be easily translatable to the clinic, where tumour cycling hypoxia
is still poorly characterised, with only a few published studies to
date (Pigott et al, 1996; Nehmeh et al, 2008). If applied in the
clinical setting, ICA-O2sat or its future versions would help
predict the temporal and spatial delivery of systemically applied
therapies, such as chemotherapy or radioimmunotherapy, in
individual patients, and consequently help tailor a more
effective delivery regime. In addition, measurements of fluctua-
tions in oxygenation could potentially provide an insight into
tumour pathophysiology in a clinical context, given the
relationships found with vascular characteristics in this study.
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